OXFD News and Press, Oxford Immunotec Global PLC From 12/10/20

The South Korean regulatory authority has approved Oxford Immunotec's ([[OXFD]] +1.3%) T-Cell Select reagent kit, an immune cell separation reagent used to automate the preparation of the cells required to run the Company’s T-SPOT.TB test, for diagnosis of TB i...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announced that the Company’s T-Cell Select reagent kit has been approved for ...

Oxford Immunotec Global (OXFD) and RIKEN Genesis Co, a subsidiary of The Sysmex Corporation (Sysmex), in Japan come together, where latter will exclusively distribute the T-SPOT Discovery SARS-CoV-2 kit, developed by Oxford Immunotec for the detection and measurement of SARS-Co...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has entered into an exclusive distribution agreement with RIKEN Genesis Co....

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to hold a virtual investor event on Thursday, December 17, 2020. Dr. Peter Wri...

Oxford Immunotec Global PLC ([[OXFD]] +0.8%) announces results from a prospective study in the U.K. that demonstrated the ability of its T-SPOT Discovery SARS-CoV-2 test to detect PCR-confirmed COVID-19 infections that were negative via blood (serology) tests for antibodies.T-SPOT, for resear...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced the release of data from a prospective cohort study in keyworkers in the UK &...

The following slide deck was published by Oxford Immunotec Global PLC in conjunction with their 2020 Q3 earnings call. For further details see: Oxford Immunotec Global PLC 2020 Q3 - Results - Earnings Call Presentation

If approved, the T-Cell Select reagent kit would enable automated sample preparation and the T-SPOT ® .TB test to be used with blood samples stored for up to 54 hours at room temperature OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Oxford...

Image source: The Motley Fool. Oxford Immunotec Global PLC (NASDAQ: OXFD) Q3 2020 Earnings Call Nov 3, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Oxford Immunotec Global PLC (OXFD) Q3 2020 Earnings Call Transcr...